3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
7
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Leukemia
3
Hodgkin Disease
3
Melanoma
2
Immunoglobulin Light-chain Amyloidosis
2
Hematologic Neoplasms
2
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Mycophenolic Acid
2
obinutuzumab
1
letermovir
1
carmustine, poliferprosan 20 drug combination
1
Tacrolimus
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Hematopoietic Stem Cell Transplantation
1
Etoposide
1
Cytarabine
1
Cyclosporins
1
Cyclosporine
1
Cyclophosphamide
1
Carmustine
1
6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic, B-Cell
×
Blood Component Removal
×
Clear all
No trials found.